LawGrids logoLAWGRIDS.ORG

Rule 18, Drugs (Prices Control) Order, 2013: Revision of ceiling price on the basis of moving annual turnover (MAT)

Drugs (Prices Control) Order, 2013 - Rule 18

Text of rule 18

Revision of ceiling price on the basis of moving annual turnover (MAT)

18. Revision of ceiling price on the basis of moving annual turnover (MAT).– The revision of ceiling prices on the basis of moving annual turnover value shall be carried out,- (i) as and when the National List of Essential Medicines is revised by the Ministry of Health and Family Welfare or five years from the date of fixing the ceiling price under this Order whichever is earlier; (ii) when the number of manufacturers of a scheduled formulation, having price of a scheduled formulation more than or equal to seventy five percent of the ceiling price fixed and notified by the Government, has decreased by twenty five percent or more than the number of manufacturers as existing on the reference date; (iii) when the number of manufacturers of a scheduled formulation, having prices of their scheduled formulation equal to or lower than twenty five percent of the ceiling price fixed by the Government, has increased by twenty five percent or more than the number of manufacturers as existing on the reference date. Explanation.- For the purpose of items (ii) and (iii) the “reference date” shall be for first revision of ceiling price May, 2012 and for second or subsequent revision the date of previous revision of the ceiling price.

Previous and next

All provisions of Drugs (Prices Control) Order, 2013

Questions people ask

Is rule 18 of Drugs (Prices Control) Order, 2013 still in force?

No repeal of Drugs (Prices Control) Order, 2013 is recorded.